Skip to Content

FLEXMycoPRRS

This page contains information on FLEXMycoPRRS for veterinary use.
The information provided typically includes the following:
  • FLEXMycoPRRS Indications
  • Warnings and cautions for FLEXMycoPRRS
  • Direction and dosage information for FLEXMycoPRRS

FLEXMycoPRRS

This treatment applies to the following species:
Company: Boehringer Ingelheim

Porcine Reproductive & Respiratory Syndrome Vaccine

Modified Live Virus

Mycoplasma Hyopneumoniae Bacterin

FLEXMycoPRRS Indications

For vaccination of healthy, susceptible swine 3 weeks of age or older as an aid in the reduction of disease caused by Mycoplasma hyopneumoniae, and as an aid in the prevention of respiratory disease due to Porcine Reproductive and Respiratory Syndrome (PRRS) virus. Indicated for use in PRRS virus positive herds only. The duration of immunity against M. hyopneumoniae is at least 26 weeks. The duration of immunity against PRRS is at least 4 months, which is throughout gestation for sows and gilts, or throughout the finishing period for pigs.

Directions and dosage: Insert a vented transfer spike into Ingelvac MycoFLEX® 2 bottle. Invert the Ingelvac PRRS® MLV 3 vaccine bottle over the Ingelvac MycoFLEX® 2 bottle and slowly insert the transfer spike, releasing the vacuum. Rotate the vials and rehydrate the Ingelvac PRRS® MLV 3 vaccine by adding a portion of the Ingelvac MycoFLEX® 2 vaccine. Shake well and transfer the reconstituted suspension back into the Ingelvac MycoFLEX® 2 bottle to complete to a total volume of 50 mL. Shake well and use immediately. Using aseptic technique, inject a single 1 mL dose intramuscularly. Semi-annual revaccination with Ingelvac MycoFLEX® is recommended for breeding swine.

Precautions

Store at 35-45°F (2-7°C). Do not freeze. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Do not vaccinate breeding age boars. PRRS vaccine virus may be shed and transmitted to other populations of swine which are in contact with vaccinated swine. The duration of potential vaccine virus transmission may vary. Burn containers and all unused contents. In case of anaphylactic reaction, epinephrine is the symptomatic treatment.

Preservative: Neomycin.

Ingelvac MycoFLEX® 2 has been tested to be non-viricidal to Ingelvac PRRS® MLV 3.

© 2015 Boehringer Ingelheim Vetmedica, Inc. All Rights Reserved.

Ingelvac MycoFLEX® and Ingelvac PRRS® are registered trademarks of Boehringer Ingelheim Vetmedica GmbH. Used under license.

Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506

US Vet. Lic. No. 124

50 Doses/Rehydrate to 50 mL

This package contains one 50 dose vial of Ingelvac MycoFLEX® 2 bacterin diluent and one 50 dose vial of Ingelvac PRRS® MLV 3 vaccine.

178001-01

250 Doses/Rehydrate to 250 mL

This package contains one 250 dose vial of Ingelvac MycoFLEX® 2 bacterin diluent and one 250 dose vial of Ingelvac PRRS® MLV 3 vaccine.

178002-00

CPN.: 1028313.0

BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
3239 SATELLITE BLVD., DULUTH, GA, 30096
Telephone:   800-325-9167
Fax:   816-236-2717
Website:   www.bevaccinesmart.com
    www.bi-vetmedica.com
    www.haveweseenyourcatlately.com
    www.metacam.com
    www.mycathasdiabetes.com
    www.prrsresearch.com
    www.prozinc.us
    www.vetera-vaccines.com
    www.vetmedin-us.com
    www.yourdogsheart.com
Email:   info@productionvalues.us
Every effort has been made to ensure the accuracy of the FLEXMycoPRRS information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2019 Animalytix LLC. Updated: 2019-09-30

Hide